1. The Rs 1,350 crore IPO of Alkem Lab was oversubscribed 33.08 times, receiving bids for 30,06,38,100 shares against the total issue size of 90,87,084 shares, data available with the NSE till 1500 hrs showed.
    
2. Similarly, the Rs 638 crore IPO of Dr Lal PathLabs received bids for 16,84,66,960 shares as against the total issue size of 81,20,000 shares, generating an over subscription of 20.75 times.
    
3. The two IPOs have seen strong response from institutional and retail investors, even though the benchmark Sensex has lost 1,133.36 points in the last six trading sessions.
    
4. Both the public issues managed to get oversubscribed on the second day of the three-day issue.
    
5. Alkem Laboratories has raised Rs 395 crore from anchor investors, including Abu Dhabi Investment Fund, by allotting shares at a price of Rs 1,050.
    
6. For the IPO, the company has fixed a price band of Rs 1,020-1,050. Through the initial share sale, which closes today, Alkem aims to raise up to Rs 1,350 crore.

This year, 18 companies have so far launched IPOs, raising more than Rs 12,000 crore, making it the best in four years in terms of fund raising through initial share-sale programs.

 

Latest News  from Business News Desk